BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3213607)

  • 1. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.
    Budden FH; Bayley TA; Harrison JE; Josse RG; Murray TM; Sturtridge WC; Kandel R; Vieth R; Strauss AL; Goodwin S
    J Bone Miner Res; 1988 Apr; 3(2):127-32. PubMed ID: 3213607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
    Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
    Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term treatment of steroid osteoporosis with fluoride.
    Bayley TA; Muller C; Harrison J; Basualdo J; Sturtridge W; Josse R; Murray TM; Pritzker KP; Vieth R; Goodwin S
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S157-61. PubMed ID: 2339626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
    Murray TM; Harrison JE; Bayley TA; Josse RG; Sturtridge WC; Chow R; Budden F; Laurier L; Pritzker KP; Kandel R
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ; Suda MK
    Clin Orthop Relat Res; 1983; (177):274-82. PubMed ID: 6407795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.
    Hasling C; Nielsen HE; Melsen F; Mosekilde L
    Miner Electrolyte Metab; 1987; 13(2):96-103. PubMed ID: 3696093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of exercise on bone mass of osteoporotic patients on fluoride treatment.
    Chow RK; Harrison JE; Sturtridge W; Josse R; Murray TM; Bayley A; Dornan J; Hammond T
    Clin Invest Med; 1987 Mar; 10(2):59-63. PubMed ID: 3581547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
    Pouillès JM; Trémollières F; Ribot C
    Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis.
    Orwoll ES; McClung MR; Oviatt SK; Recker RR; Weigel RM
    J Bone Miner Res; 1989 Feb; 4(1):81-8. PubMed ID: 2718782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
    Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histomorphometric study of pelvic-crest biopsies during long-term fluoride treatment of osteoporosis (author's transl)].
    Hauswaldt C; Fuchs C; Hesch RD; Köbberling J; Unger KO
    Dtsch Med Wochenschr; 1977 Aug; 102(33):1177-80. PubMed ID: 891415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
    Fratzl P; Roschger P; Eschberger J; Abendroth B; Klaushofer K
    J Bone Miner Res; 1994 Oct; 9(10):1541-9. PubMed ID: 7817799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
    Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
    J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
    J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis therapy and thyroid function. Influence of 6 months of sodium fluoride treatment on thyroid function and bone density].
    Eichner R; Börner W; Henschler D; Köhler W; Moll E
    Fortschr Med; 1981 Mar; 99(10):342-8. PubMed ID: 7216100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
    Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
    Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
    Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.